ApoTox-Glo™ Triplex Assay

ApoTox-Glo™ Triplex Assay
by Promega Corp.
 3.6/5.0 (1 review)

The ApoTox-Glo™ Triplex Assay combines three assay chemistries to easily assess viability, cytotoxicity and apoptosis events in the same cell-based assay well. First, viability and cytotoxicity are determined by measuring two differential protease biomarkers simultaneously with the addition of a single nonlytic reagent containing two peptide substrates. The live-cell protease activity is restricte...read more

Request Pricing




Receive your quote directly from Promega Corp. for ApoTox-Glo™ Triplex Assay

Reviews

AVERAGE RATING: 3.6

1 scientist has reviewed this product

Write your own review



  • 3 out of 5EASE OF USE
  • 5 out of 5AFTER SALES SERVICE
  • 3 out of 5VALUE FOR MONEY

BROOKE HELFER


Status:


See all reviews
Member since 2011

Organization:
CELSENSE INC
Read more »
RATING: 3.6

  • 3 out of 5EASE OF USE
  • 5 out of 5AFTER SALES SERVICE
  • 3 out of 5VALUE FOR MONEY




Review date: 03 Aug 2011

ApoTox-Glo™ Triplex Assay

"Takes a bit of optimization but the multiplex-ability is worth it."

Description

 

The ApoTox-Glo™ Triplex Assay combines three assay chemistries to easily assess viability, cytotoxicity and apoptosis events in the same cell-based assay well. First, viability and cytotoxicity are determined by measuring two differential protease biomarkers simultaneously with the addition of a single nonlytic reagent containing two peptide substrates. The live-cell protease activity is restricted to intact viable cells and is measured using a fluorogenic, cell-permeant peptide substrate (GF-AFC Substrate).

The substrate enters intact cells, where it is cleaved to generate a fluorescent signal proportional to the number of living cells. This live-cell protease activity marker becomes inactive upon loss of membrane integrity and leakage into the surrounding culture medium. A second, cell-impermeant, fluorogenic peptide substrate (bis-AAF-R110 Substrate) is used simultaneously to measure dead-cell protease activity that has been released from cells that have lost membrane integrity. This results in ratiometric, inversely correlated measures of cell viability and cytotoxicity. The ratio of viable cells to dead cells is independent of cell number and, therefore, can be used to normalize data. A second reagent containing luminogenic DEVD-peptide substrate for caspase-3/7 and Ultra-Glo™ Recombinant Thermostable Luciferase is added. Caspase-3/7 cleavage of the substrate releases luciferin, which is a substrate for luciferase and generates light. The light output, measured with a luminometer, correlates with caspase-3/7 activation as a key indicator of apoptosis.

Features - Benefits

• Measure Viability, Cytotoxicity and Apoptosis in the Same Sample Well: Determine mechanism of cell death for cells in the same sample well.
• Easily Implement: Assay follows a simple sequential "add-mix-measure" format.
• Normalize Data with a Built-In Control: The ratio of the number of live cells/number of dead cells is independent of cell number and normalizes data. This normalization makes results more comparable well-to-well, plate-to-plate and day-to-day.
• Flexible and Easily Automated: The volumes of each assay component can be scaled to meet throughput needs and is amenable to automation in 96- and 384-well plates.
• Improves Efficiency and Saves on Lab Budget: Reduces cell culture and labor costs by performing three assays in a single well.

Applications

• Determine mechanism of cell death.
• Profile compound libraries for cytotoxic risk.

Product Overview

ApoTox-Glo™ Triplex Assay by Promega Corp.
ApoTox-Glo™ Triplex Assay




  • 3out of 5EASE OF USE
  • 5 out of 5AFTER SALES SERVICE
  • 3 out of 5VALUE FOR MONEY





Request Pricing

SelectScience Trusted Banner

Why make an inquiry with SelectScience?

Advertisement

Advertisement